ResMed Inc. (NYSE:NYSE:RMD) Q3 2022 Earnings Conference Call April 28, 2022, 04:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO Brett.
SAN DIEGO – ResMed has “five lines of work” to pump more of its CPAP devices into the market amid ongoing supply chain challenges, including a new AirSense